Skip to main content

Table 3 The Risk of Recurrence of Ischemic Stroke and Hemorrphagic Stroke in association with Antidepressants

From: Using antidepressants and the risk of stroke recurrence: report from a national representative cohort study

 

Ischemic Stroke

Hemorrhagic Stroke

 

Number of Recurrent Stroke/Person-years

Rate per 1000 Person-Years

Crude HR

(95 % CI)

Adjusted HRa

(95 % CI)

Number of Recurrent Stroke/Person-years

Rate per 1000 Person-Years

Crude HR

(95 % CI)

Adjusted HRa

(95 % CI)

Non-use of Antidepressants

3012/61194

49.2

1

 

1

 

681/68749

9.9

1

 

1

 

Use of Antidepressants

217/2521

86.1

1.58

(1.38, 1.82)

1.48

(1.28, 1.70)

35/3098

11.3

1.10

(0.78, 1.54)

1.22

(0.86, 1.73)

Type of Antidepressants

 TCAs only

83/930

945.2

1.64

(1.32, 2.04)

1.53

(1.23, 1.90)

12/1113

10.8

1.03

(0.58, 1.83)

1.08

(0.61, 1.91)

 SSRIs only

49/653

649.7

1.46

(1.10, 1.93)

1.34

(1.01, 1.79)

8/794

10.1

1.03

(0.51, 2.06)

1.23

(0.61, 2.48)

 MAOIs only

8/93

92.6

1.36

(0.68, 2.72)

1.24

(0.62, 2.49)

2/111

18.0

1.53

(0.38, 6.11)

2.15

(0.54, 8.68)

 Others only

11/92

761.1

1.59

(1.24, 2.03)

1.50

(1.17, 1.92)

10/963

10.4

1.01

(0.54, 1.88)

1.12

(0.60, 2.10)

 Multiple types

66/756

92.2

2.06

(1.14, 3.73)

1.95

(1.08, 3.54)

3/117

25.7

2.51

(0.81, 7.80)

2.78

(0.89, 8.68)

Dose Group+

 <0.5 DDDs

116/1322

87.7

1.58

(1.31, 1.90)

1.49

(1.23, 1.79)

16/1638

9.8

0.93

(0.57, 1.53)

1.00

(0.61, 1.64)

 0.5–1 DDDs

46/502

91.7

1.73

(1.29, 2.31)

1.59

(1.19, 2.13)

6/617

9.7

0.97

(0.44, 2.18)

1.11

(0.50, 2.49)

 > = 1 DDDs

55/697

78.9

1.48

(1.13, 1.93)

1.37

(1.05, 1.80)

13/844

15.4

1.53

(0.89, 2.66)

1.81

(1.04, 3.16)

  1. HR indicates hazard ratio; 95 % CI: 95 % confidence interval
  2. +Dose Group = The Average Dose of the Prescriptions for Antidepressants per day/Defined Daily Dose; unit: DDDs
  3. aAdjusted for sex, age group, stroke type of the first hospitalization, antipsychotics, antithrombotic agents, anticoagulant, antiplatelet, antidepressant drugs use before stroke, depression, anxiety or other mood disorders, atrial fibrillation, coronary heart disease, congestive heart failure, COPD, cancer, diabetes mellitus or medicine treatment, hypertension or medicine treatment, hyperlipidemia or medicine treatment